摘要
目的:分析麝香保心丸联合美托洛尔及曲美他嗪治疗冠心病心力衰竭的临床研究。方法:将56例冠心病心力衰竭患者56例随机分为两组,对照组患者行常规治疗,观察组患者采用麝香保心丸治疗,对比两种治疗方式效果。结果:观察组患者治疗后心率、左心室射血分数、生活质量、不良反应对比对照组,差异有统计学意义(P<0.05)。结论:为冠心病心力衰竭患者采用麝香保心丸联合美托洛尔、曲美他嗪治疗时疗效显著。
Objective: To study the clinical study on the treatment of heart failure in patients with coronary heart disease(CHD) with the combination of Shexiang Baoxin Pill and metoprolol and trimetanol. Methods: 56 cases patients with coronary heart disease and heart failure were randomly divided into two groups. Patients in the control group received conventional treatment. Patients in the observation group were treated with Shexiang Baoxin Pill. The effects of the two treatment methods were compared. Results: The heart rate, left ventricular ejection fraction, quality of life and adverse reactions in the observation group were significantly different from those in the control group(P<0.05). Conclusion: The use of Shexiang Baoxin Pill in patients with heart failure of the patients with coronary heart disease The curative effect of metoprolol and trimefloxacin in the treatment is remarkable.
作者
余细宝
YU Xi-bao(Internal Medicine of Department,Taihe Hospital of Traditional Chinese Medicine,Ji’an Jiangxi343700,China)
出处
《药品评价》
CAS
2019年第18期31-32,共2页
Drug Evaluation